BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He C, Liu Y, Li J, Zheng X, Liang J, Cui G, Chang H. LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer. Bioengineered 2022;13:8699-711. [PMID: 35322746 DOI: 10.1080/21655979.2022.2054754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Siri G, Yazdani O, Esbati R, Akhavanfar R, Asadi F, Adili A, Ebrahimzadeh F, Hosseini SME. A comprehensive review of the role of lncRNAs in gastric cancer (GC) pathogenesis, immune regulation, and their clinical applications. Pathol Res Pract 2023;241:154221. [PMID: 36563559 DOI: 10.1016/j.prp.2022.154221] [Reference Citation Analysis]
2 Li D, Shen Y, Ren H, Wang L, Yang J, Wang Y. Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer. Cell Cycle 2023;22:255-68. [PMID: 36045598 DOI: 10.1080/15384101.2022.2112132] [Reference Citation Analysis]
3 Wang G, Dong Y, Liu H, Ji N, Cao J, Liu A, Tang X, Ren Y. Long noncoding RNA (lncRNA) metallothionein 1 J, pseudogene (MT1JP) is downregulated in triple-negative breast cancer and upregulates microRNA-138 (miR-138) to downregulate hypoxia-inducible factor-1α (HIF-1α). Bioengineered 2022;13:13718-27. [PMID: 35703312 DOI: 10.1080/21655979.2022.2077906] [Reference Citation Analysis]